Periodic Reporting for period 1 - Inhibicov (Hit-to-Lead Development of potent broad-spectrum coronavirus fusion inhibitors)

The COVID-19 pandemic has highlighted the urgent need for effective therapeutic strategies to combat viral infections. Antiviral drugs are crucial in this context as they can help reduce hospitalizations, prevent chronic late effects, shorten the infection period, and reduce...